Cargando…
CCR2-overexpressing mesenchymal stem cells targeting damaged liver enhance recovery of acute liver failure
BACKGROUND: Mesenchymal stem cell (MSC) transplantation is emerging as a promising cell therapeutic strategy in acute liver failure (ALF) clinical research. The potency of MSCs to migrate and engraft into targeted lesions could largely determine their clinical efficacy, in which chemokine/receptor a...
Autores principales: | Xu, Ruixuan, Ni, Beibei, Wang, Li, Shan, Jiarou, Pan, Lijie, He, Yizhan, Lv, Guo, Lin, Huizhu, Chen, Wenjie, Zhang, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817567/ https://www.ncbi.nlm.nih.gov/pubmed/35123561 http://dx.doi.org/10.1186/s13287-022-02729-y |
Ejemplares similares
-
Human umbilical cord-derived mesenchymal stem cells ameliorate experimental colitis by normalizing the gut microbiota
por: Yang, Fan, et al.
Publicado: (2022) -
Key genes associated with non-alcoholic fatty liver disease and hepatocellular carcinoma with metabolic risk factors
por: Yang, Fan, et al.
Publicado: (2023) -
Impact of Bevacizumab on parenchymal damage and functional recovery of the liver in patients with colorectal liver metastases
por: Volk, Andreas M., et al.
Publicado: (2016) -
Overexpression of c-Met in bone marrow mesenchymal stem cells improves their effectiveness in homing and repair of acute liver failure
por: Wang, Kun, et al.
Publicado: (2017) -
Mesenchymal stem cells ameliorate lipid metabolism through reducing mitochondrial damage of hepatocytes in the treatment of post-hepatectomy liver failure
por: Wang, Jing-lin, et al.
Publicado: (2021)